The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.25%)
Open: 165.00
High: 165.00
Low: 165.00
Prev. Close: 165.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reinsurance Agreement

26 Jul 2013 11:21

RNS Number : 2468K
Hampden Underwriting Plc
26 July 2013
 



26 July 2013

 

Hampden Underwriting PLC

("Hampden Underwriting" or the "Company")

 

Reinsurance releases capital for reinvestment in new opportunities

 

Hampden Underwriting, which provides investors with a limited liability direct investment into the Lloyd's insurance market, is pleased to announce the significant release of capital achieved by way of an annually renewable reinsurance arrangement.

 

Overview of the transaction

 

§ Collateralised quota share reinsurance agreement commencing with 2013 year of account

§ 50% of the Company's 2013 insurance exposure ceded to reinsurer

§ Release of £4.1m (approximately 50%) of the Company's £8.2m of Funds at Lloyd's) for reinvestment in new opportunities

§ Ratcheted, performance-based profit commission payable to the Company of between 10% and 20% of the profits arising on business ceded in each period

§ Minimum term of one year renewable annually thereafter

 

 

Commenting upon this transaction Sir Michael Oliver, the Company's Chairman, said:

"This transaction presents Hampden Underwriting with a welcome source of capital with which to fund near-term opportunities the Company wishes to pursue and does so on attractive commercial terms. The Board regularly considers the relative merits of alternative sources of capital and is confident that this is an appropriate funding option at this time."

 

Commenting upon this transaction Nigel Hanbury, the Company's Chief Executive, said:

 

"Current market conditions continue to present the Company with attractive investment opportunities which require funding. We are delighted to have been able to successfully conclude this transaction which provides the Company with a modest war chest with which we can continue to progress acquisition opportunities. The reinsurance terms provide a profit commission in good underwriting years and a reduced risk exposure in disappointing underwriting years in a spectrum that is both equitable and commercially attractive. Its annually renewable feature provides Hampden Underwriting with certainty for 2013 as well as the appropriate opportunity to review the arrangement from time to time."

 

 

 

For further information please contact:

Hampden Underwriting

 

Nigel Hanbury

nigel.hanbury@hampdenplc.com

Smith & Williamson Corporate Finance

 

David Jones

020 7131 4000

 

Additional information on the reinsurance arrangements

The Company has entered a reinsurance agreement with Hampden Insurance PCC (Guernsey) Limited - Cell 6 ("Cell 6"), a newly-formed special purpose vehicle. On a back-to-back basis, Cell 6 has reinsured the reinsurance risk with Bermudan reinsurer, XL Re Ltd ("XL"), part of global NYSE-quoted insurer XL Group plc.

 

The key terms of the arrangements are as follows:

- XL will take on via Cell 6 the risks and rewards of 50% of the Company's existing 2013 underwriting activities (although the activities themselves and the underwriting capacity will remain the Company's);

- XL will provide a letter of credit to Lloyd's in an amount of £4.1m (approximately 50% of the Company's existing funds at Lloyd's ("FAL"), enabling an equivalent amount to be released from FAL to the Company;

- XL will pay a profit commission of between 10% and 20% of profits from the business ceded to the Company (via Cell 6) depending on the results of the relevant insurance years of account;

- XL will pay a fee to Cell 6 of 1.5% per year of account of the value of the letter of credit provided to Lloyd's and Cell 6 will pay this on to the Company, less the Company's share of Cell 6's management fees, costs and expenses which is estimated to be approximately £12,500 per annum; and

- the reinsurance arrangements apply to the Company's 2013 year of account and are renewable annually thereafter.

 

Cell 6 is ultimately 51% owned by Nigel Hanbury (a director and 14.8% shareholder in the Company) and 49% by Hampden Capital plc (a 11.9% shareholder in the Company). Nigel Hanbury and a number of Lloyd's underwriting entities ultimately owned by him and his family have entered reinsurance agreements with Cell 6 on a pari passu basis. The terms of the transaction have been approved by the independent members of the Company's board of directors.

 

 

About Hampden Underwriting plc

Hampden Underwriting plc has been incorporated primarily to provide a limited liability direct investment into the Lloyd's insurance market. Hampden Underwriting plc is quoted on the London Stock Exchange's AIM market (ticker: HUW). For further information please visit www.hampdenplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNARROBABUAR
Date   Source Headline
30th Jun 20157:00 amRNSIssue of Equity
25th Jun 20154:11 pmRNSResult of AGM
19th Jun 201511:47 amRNSDirector/PDMR Shareholding
12th Jun 20155:25 pmRNSCompletion of Acquisition
12th Jun 20157:00 amRNSScript Dividend Reference Price
5th Jun 20157:00 amRNSSyndicate Forecasts
2nd Jun 20159:42 amRNSPosting of Annual Report & Notice of AGM
26th May 20158:06 amRNSFinal Results
31st Mar 201512:04 pmRNSTotal Voting Rights
17th Mar 20157:00 amRNSSyndicate Forecasts
13th Mar 20154:02 pmRNSAcquisition
11th Mar 201511:35 amRNSDirector/PDMR Shareholding
20th Feb 20154:12 pmRNSCompletion of Acquisition
18th Feb 20153:45 pmRNSDirector/PDMR Shareholding
18th Feb 20157:00 amRNSDirector/PDMR Shareholding
17th Feb 20157:00 amRNSAcquisition
16th Feb 20157:00 amRNSAcquisition
13th Feb 20154:08 pmRNSHolding(s) in Company
12th Feb 20157:00 amRNSAcquisition
9th Jan 20157:00 amRNSAcquisition
19th Dec 20143:55 pmRNSChange of Registered Office
19th Dec 20143:38 pmRNSAcquisition
26th Nov 20147:00 amRNSSyndicate Forecasts
29th Sep 20147:00 amRNSHalf Yearly Report
17th Sep 201411:52 amRNSCompletion of Acquisition
27th Aug 20147:00 amRNSSyndicate Forecasts
23rd Jul 20143:51 pmRNSSyndicate Forecasts
23rd Jul 20141:44 pmRNSHolding(s) in Company
23rd Jul 20147:00 amRNSHolding(s) in Company
14th Jul 20143:32 pmRNSHolding(s) in Company
14th Jul 20147:00 amRNSHUW Secures Stop Loss Cover
9th Jul 20147:00 amRNSAcquisition
8th Jul 20143:40 pmRNSHolding(s) in Company
1st Jul 201412:21 pmRNSHolding(s) in Company
30th Jun 20145:45 pmRNSHolding(s) in Company
30th Jun 20147:00 amRNSReinsurance Agreements
27th Jun 201410:03 amRNSResult of AGM
4th Jun 20147:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20147:00 amRNSFinal Results
8th May 20149:04 amRNSCompletion of Acquisition
2nd May 20141:17 pmRNSAcquisition of Lloyd's Member
28th Mar 20147:00 amRNSAcquisition of Corporate Member
27th Mar 20147:00 amRNSSyndicate Forecasts
12th Mar 20147:00 amRNSChange of Adviser
5th Mar 201411:30 amRNSMembers' Agent's Agreements
20th Feb 20143:57 pmRNSHolding(s) in Company
30th Jan 20142:17 pmRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSChange of Name
17th Jan 20143:13 pmRNSCompletion of Acquisitiion
13th Jan 20141:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.